Limin Xu

2.6k total citations · 1 hit paper
58 papers, 1.9k citations indexed

About

Limin Xu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Limin Xu has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Limin Xu's work include Natural Compounds in Disease Treatment (9 papers), Lipoproteins and Cardiovascular Health (4 papers) and MicroRNA in disease regulation (4 papers). Limin Xu is often cited by papers focused on Natural Compounds in Disease Treatment (9 papers), Lipoproteins and Cardiovascular Health (4 papers) and MicroRNA in disease regulation (4 papers). Limin Xu collaborates with scholars based in China, United States and France. Limin Xu's co-authors include Fanfan Cao, Denghai Zhang, Ruijuan Zhou, Hongzhi Du, Min Liao, Bin Peng, Georges Uzan, Mingming Jin, Liying Cai and Yufeng Jiang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Limin Xu

52 papers receiving 1.9k citations

Hit Papers

Facilitating alkaline hydrogen evolution reaction on the ... 2024 2026 2025 2024 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Limin Xu China 23 957 343 245 199 152 58 1.9k
Lili Wang China 28 868 0.9× 202 0.6× 106 0.4× 121 0.6× 82 0.5× 140 2.1k
Congcong Chen China 25 917 1.0× 135 0.4× 124 0.5× 452 2.3× 41 0.3× 80 1.9k
Hao Wu China 29 982 1.0× 166 0.5× 164 0.7× 332 1.7× 28 0.2× 133 2.7k
Jiawen Wang China 21 849 0.9× 112 0.3× 446 1.8× 479 2.4× 51 0.3× 76 2.0k
Yang Yuan China 28 881 0.9× 466 1.4× 423 1.7× 410 2.1× 29 0.2× 129 2.5k
Chunmei Cao China 28 1.7k 1.8× 143 0.4× 245 1.0× 519 2.6× 82 0.5× 67 3.2k
Yujiao Wang China 24 887 0.9× 320 0.9× 151 0.6× 133 0.7× 21 0.1× 98 1.7k
Huijuan Wang China 24 1.3k 1.4× 412 1.2× 51 0.2× 135 0.7× 37 0.2× 101 2.2k
Andrea Ragusa Italy 26 569 0.6× 144 0.4× 190 0.8× 383 1.9× 40 0.3× 56 1.8k
Lingyu Zeng China 27 1.1k 1.1× 230 0.7× 110 0.4× 379 1.9× 31 0.2× 219 3.2k

Countries citing papers authored by Limin Xu

Since Specialization
Citations

This map shows the geographic impact of Limin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limin Xu more than expected).

Fields of papers citing papers by Limin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limin Xu. The network helps show where Limin Xu may publish in the future.

Co-authorship network of co-authors of Limin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Limin Xu. A scholar is included among the top collaborators of Limin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limin Xu. Limin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yin, Ping, Min Yang, Rong Shi, et al.. (2025). Efficacy and Safety of Electroacupuncture on Insomnia in Parkinson's Disease: A Multicentre, Randomized, Controlled Trial. Movement Disorders Clinical Practice. 12(10). 1589–1601.
3.
Liang, Jiechun, et al.. (2025). A Dataset of Raman and Infrared Spectra as an Extension to the ChEMBL. Scientific Data. 12(1). 939–939. 1 indexed citations
4.
Hu, Xiwen, Na Li, Limin Xu, et al.. (2024). Kidney targeted delivery of siRNA mediated by peptide-siRNA conjugate for the treatment of acute kidney injury. Chinese Chemical Letters. 36(6). 110251–110251. 2 indexed citations
5.
6.
Zhu, Yiming, Malte Klingenhof, Chenlong Gao, et al.. (2024). Facilitating alkaline hydrogen evolution reaction on the hetero-interfaced Ru/RuO2 through Pt single atoms doping. Nature Communications. 15(1). 1447–1447. 260 indexed citations breakdown →
8.
Xu, Limin, Jing Zhang, Yingqiang Li, et al.. (2023). ScRNAPip: A systematic and dynamic pipeline for single‐cell RNA sequencing analysis. SHILAP Revista de lepidopterología. 2(4). e132–e132. 9 indexed citations
9.
Feng, Tienan, Wei Yang, Qiang Li, et al.. (2023). Association of statin use and increase in lipoprotein(a): a real-world database research. European journal of medical research. 28(1). 212–212. 4 indexed citations
10.
Xu, Limin, et al.. (2023). Research on the Measurement of the Modernization Level and Efficiency Changes of the Economic System. International Journal of Current Science Research and Review. 6(8). 1 indexed citations
11.
Wang, Ying, Qiuyun Liu, Haojie Chen, et al.. (2018). Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anti-Cancer Drugs. 29(8). 748–755. 17 indexed citations
12.
Chen, Qing, Xinghui Liu, Limin Xu, et al.. (2016). Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion. Oncology Reports. 35(4). 1916–1924. 44 indexed citations
13.
Wang, Ying, Lu Cao, Limin Xu, et al.. (2015). Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems. Journal of Neuroimmune Pharmacology. 10(3). 506–516. 34 indexed citations
14.
Peng, Bin, Xue Zhang, Fanfan Cao, et al.. (2014). Peptide deformylase inhibitor actinonin reduces celastrol’s HSP70 induction while synergizing proliferation inhibition in tumor cells. BMC Cancer. 14(1). 146–146. 3 indexed citations
15.
Xu, Limin, et al.. (2013). Decreasing operating potential for water electrolysis to hydrogen via local confinement of iron-based soft coordination suprapolymers. Physical Chemistry Chemical Physics. 15(38). 15912–15912. 1 indexed citations
16.
Zheng, Yuejuan, Yang Yang, Yuhu Li, et al.. (2013). Ephedrine hydrochloride inhibits PGN-induced inflammatory responses by promoting IL-10 production and decreasing proinflammatory cytokine secretion via the PI3K/Akt/GSK3β pathway. Cellular and Molecular Immunology. 10(4). 330–337. 48 indexed citations
17.
Jiang, Danjie, Dawei Zheng, Lingyan Wang, et al.. (2013). Elevated PLA2G7 Gene Promoter Methylation as a Gender-Specific Marker of Aging Increases the Risk of Coronary Heart Disease in Females. PLoS ONE. 8(3). e59752–e59752. 72 indexed citations
18.
Xu, Limin, Jianqing Zhou, R. Stephanie Huang, et al.. (2013). An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A2 and coronary heart disease. Experimental and Therapeutic Medicine. 5(3). 742–750. 21 indexed citations
19.
Huang, Yi, Jiangfang Lian, R. Stephanie Huang, et al.. (2012). Positive Association Between rs10918859 of the NOS1AP Gene and Coronary Heart Disease in Male Han Chinese. Genetic Testing and Molecular Biomarkers. 17(1). 25–29. 16 indexed citations
20.
Peng, Ping, Jiangfang Lian, R. Stephanie Huang, et al.. (2012). Meta-Analyses of KIF6 Trp719Arg in Coronary Heart Disease and Statin Therapeutic Effect. PLoS ONE. 7(12). e50126–e50126. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026